Mental Illness Medicine Company Hansoh Pharma’s IPO At Hong Kong Exchange

Hansoh Pharma's IPO was set at 14.26 HKD per stock, at this moment, the stock price of Hansoh Pharma is around 20 HKD with 118.68 billion HKD market value. About 551 million new shares were issued this time, of which the international ratio was 93%, and the Hong Kong ratio was 7%. 45% of the funds raised will be invested in the research and development of new drugs, 25% will be used in the building of the production system, and the remaining 20% will be used in sales and promotion.

Founded in 1995, Hansoh Pharma focuses on the fields of the central nervous system, anti-tumor, anti-infective and diabetes. The company has a variety of technologies and holds a total of 119 patents in China. According to Hansoh Pharma's plan, the company will launch nearly 30 new drugs between 2019 and 2020.

From 2016 to 2018, Hansoh Pharma a net profit of 1.47, 1.59, 1.9 billion RMB, Hansoh Pharma's gross profit margin was 92.6%, 92.7%, and 92.6%, respectively, and the net profit margin was 28.7%, 27.2%, and 25.8%.